Anagin, Inc. — Form D
Anagin, Inc. of INDIANAPOLIS, IN, a company, filed a Form D exempt-offering notice with the SEC on 2018-06-29. The offering totals $1.4M, of which $1.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2018-06-29
- Form: D
- Accession: 0001679399-18-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.4M
- Amount sold: $1.3M
- Remaining: $91K
- Investors: 20
- Date of first sale: 2018-06-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-315793
Issuer
- Name: Anagin, Inc.
- CIK: 0001679399
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: INDIANA CTR FOR BIOMEDIC. INNOV. NOYES P, INDIANAPOLIS, IN, 46202
- Phone: (317) 652-1840
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Nora Doherty | Director | CARMEL, IN |
| Frank French | Director | Indianapolis, IN |
| Jaswant Gidda | Director | Indianapolis, IN |
| Anantha Shekhar | Director | Indianapolis, IN |
| Derek Small | Director | Carmel, IN |
| Jaswant Gidda | Executive Officer | Indianapolis, IN |
| Yvonne Lai | Executive Officer | Indianapolis, IN |
| James Schulz | Executive Officer | New York, NY |
Other filings by this issuer (2)
More